Medical Director
Enanta Pharmaceuticals
Watertown, MA, United States
Christopher Harris, MD, FAAP is a pediatric pulmonologist currently at Enanta Pharmaceuticals as Medical Director, Infectious Disease. He has held positions at prestigious institutions such as Cedars-Sinai Medical Center and Vanderbilt University along with roles in clinical development at Vertex Pharmaceuticals..
Dr. Harris's research interests have centered on pediatric respiratory illnesses, particularly cystic fibrosis (CF) and asthma. He has been a principal investigator on several clinical trials for the Cystic Fibrosis Foundation and pharmaceutical companies, focusing on new therapies for CF. His academic work includes publications in peer-reviewed journals such as the American Journal of Respiratory Cell and Molecular Biology and Pediatrics. He has also authored book chapters and reviews on topics like aerosol therapies for CF and pediatric pneumonia.
In addition to his clinical and research work, Dr. Harris has a strong commitment to medical education and professional service. He has served in leadership roles for organizations like the American Academy of Pediatrics Section on Pediatric Pulmonology and GLMA . His service extends to community mentorship and advocacy for diversity and inclusion in healthcare.
Disclosure information not submitted.